AR and neoplasm: The mechanism of progression from androgen dependent to independent disease remains poorly understood.[5–7] It is thought that tumor cells either bypass or alter the AR activation pathway to allow continued growth, e.g., by AR amplification, mutation or modification or that hormone refractory cells may express aberrant levels of cofactors or activate the AR via alternative signaling pathways.